
Minh Duc Gia Pham
Examiner (ID: 9692, Phone: (571)270-1789 , Office: P/3762 )
| Most Active Art Unit | 3762 |
| Art Unit(s) | 3792, 3762 |
| Total Applications | 288 |
| Issued Applications | 178 |
| Pending Applications | 1 |
| Abandoned Applications | 111 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17443640
[patent_doc_number] => 20220064145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => SYNTHESIS OF POZIOTINIB DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 17/458031
[patent_app_country] => US
[patent_app_date] => 2021-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3576
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 199
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17458031
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/458031 | SYNTHESIS OF POZIOTINIB DERIVATIVE | Aug 25, 2021 | Abandoned |
Array
(
[id] => 18724126
[patent_doc_number] => 20230338246
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => ANTIPERSPIRANT STICK COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/004997
[patent_app_country] => US
[patent_app_date] => 2021-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7053
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18004997
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/004997 | ANTIPERSPIRANT STICK COMPOSITIONS | Jul 8, 2021 | Pending |
Array
(
[id] => 17314373
[patent_doc_number] => 20210403421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => BIODEGRADABLE SURFACTANTS AND RELATED COMPOSITIONS, METHODS AND SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 17/350875
[patent_app_country] => US
[patent_app_date] => 2021-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32751
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17350875
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/350875 | BIODEGRADABLE SURFACTANTS AND RELATED COMPOSITIONS, METHODS AND SYSTEMS | Jun 16, 2021 | Pending |
Array
(
[id] => 20593555
[patent_doc_number] => 12577257
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-17
[patent_title] => Heterocyclic compounds
[patent_app_type] => utility
[patent_app_number] => 17/325934
[patent_app_country] => US
[patent_app_date] => 2021-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21402
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 229
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17325934
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/325934 | Heterocyclic compounds | May 19, 2021 | Issued |
Array
(
[id] => 18468740
[patent_doc_number] => 20230203022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => HETEROCYCLE AND GLUTARIMIDE SKELETON-BASED COMPOUND AND APPLICATIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/922124
[patent_app_country] => US
[patent_app_date] => 2021-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18874
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17922124
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/922124 | HETEROCYCLE AND GLUTARIMIDE SKELETON-BASED COMPOUND AND APPLICATIONS THEREOF | Apr 28, 2021 | Pending |
Array
(
[id] => 18724220
[patent_doc_number] => 20230338345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => DRUG COMBINATION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/918604
[patent_app_country] => US
[patent_app_date] => 2021-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21985
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17918604
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/918604 | DRUG COMBINATION AND USE THEREOF | Apr 21, 2021 | Pending |
Array
(
[id] => 18657630
[patent_doc_number] => 20230303557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => CRYSTALLINE FORM OF TLR8 AGONIST
[patent_app_type] => utility
[patent_app_number] => 17/931456
[patent_app_country] => US
[patent_app_date] => 2021-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6344
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17931456
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/931456 | Crystalline form of TLR8 agonist | Mar 17, 2021 | Issued |
Array
(
[id] => 18282782
[patent_doc_number] => 20230098254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => SCUTELLARIAE RADIX COMPOUNDS AND USE THEREOF FOR INHIBITING OXIDATIVE PHOSPHORYLATION PATHWAY OF MITOCHONDRIA
[patent_app_type] => utility
[patent_app_number] => 17/909422
[patent_app_country] => US
[patent_app_date] => 2021-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16644
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17909422
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/909422 | SCUTELLARIAE RADIX COMPOUNDS AND USE THEREOF FOR INHIBITING OXIDATIVE PHOSPHORYLATION PATHWAY OF MITOCHONDRIA | Mar 7, 2021 | Pending |
Array
(
[id] => 16898072
[patent_doc_number] => 20210176988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => LIQUID FORMULATION OF BIPHENYL-CONTAINING COMPOUND AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/187877
[patent_app_country] => US
[patent_app_date] => 2021-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5835
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17187877
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/187877 | Liquid formulation of biphenyl-containing compound and application thereof | Feb 27, 2021 | Issued |
Array
(
[id] => 18466856
[patent_doc_number] => 20230201136
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => METHODS AND MATERIALS FOR DIAGNOSIS AND TREATMENT OF NEURONAL DISORDER
[patent_app_type] => utility
[patent_app_number] => 17/802908
[patent_app_country] => US
[patent_app_date] => 2021-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15091
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17802908
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/802908 | Methods and materials for diagnosis and treatment of neuronal disorder | Feb 25, 2021 | Issued |
Array
(
[id] => 18307098
[patent_doc_number] => 20230110998
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => Compositions and Methods for Treatment of Cytokine Storm and Cytokine Release Syndrome
[patent_app_type] => utility
[patent_app_number] => 17/801434
[patent_app_country] => US
[patent_app_date] => 2021-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7163
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17801434
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/801434 | Compositions and Methods for Treatment of Cytokine Storm and Cytokine Release Syndrome | Feb 23, 2021 | Pending |
Array
(
[id] => 18752328
[patent_doc_number] => 20230355553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING OCULAR DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/799149
[patent_app_country] => US
[patent_app_date] => 2021-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18678
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17799149
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/799149 | COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING OCULAR DISORDERS | Feb 10, 2021 | Pending |
Array
(
[id] => 17005345
[patent_doc_number] => 20210236506
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => NOVEL USES
[patent_app_type] => utility
[patent_app_number] => 17/173069
[patent_app_country] => US
[patent_app_date] => 2021-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6210
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17173069
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/173069 | NOVEL USES | Feb 9, 2021 | Abandoned |
Array
(
[id] => 18268288
[patent_doc_number] => 20230089530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => QUINUCLIDINONE ANALOGUES AS ANTICANCER AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/797772
[patent_app_country] => US
[patent_app_date] => 2021-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29397
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 236
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17797772
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/797772 | QUINUCLIDINONE ANALOGUES AS ANTICANCER AGENTS | Feb 4, 2021 | Pending |
Array
(
[id] => 20756978
[patent_doc_number] => 12649737
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-06-09
[patent_title] => Compounds and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/795929
[patent_app_country] => US
[patent_app_date] => 2021-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26758
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17795929
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/795929 | Compounds and uses thereof | Jan 28, 2021 | Issued |
Array
(
[id] => 18228283
[patent_doc_number] => 20230067277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => ANALOGUES OF MYCOSPORINE-LIKE AMINO ACID AND USE THEREOF AS SUNSCREENS
[patent_app_type] => utility
[patent_app_number] => 17/793669
[patent_app_country] => US
[patent_app_date] => 2021-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7390
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17793669
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/793669 | ANALOGUES OF MYCOSPORINE-LIKE AMINO ACID AND USE THEREOF AS SUNSCREENS | Jan 19, 2021 | Abandoned |
Array
(
[id] => 19210699
[patent_doc_number] => 11999747
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-04
[patent_title] => Furoquinolinediones as inhibitors of TDP2
[patent_app_type] => utility
[patent_app_number] => 17/146327
[patent_app_country] => US
[patent_app_date] => 2021-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11634
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 284
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17146327
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/146327 | Furoquinolinediones as inhibitors of TDP2 | Jan 10, 2021 | Issued |
Array
(
[id] => 17299442
[patent_doc_number] => 20210395281
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => MACROCYCLIC CHELATES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/272129
[patent_app_country] => US
[patent_app_date] => 2021-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26289
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -58
[patent_words_short_claim] => 179
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17272129
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/272129 | MACROCYCLIC CHELATES AND USES THEREOF | Jan 7, 2021 | Pending |
Array
(
[id] => 18451330
[patent_doc_number] => 20230192607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => TRANSCRIPTIONAL ENHANCED ASSOCIATE DOMAIN (TEAD) TRANSCRIPTION FACTOR INHIBITORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/789023
[patent_app_country] => US
[patent_app_date] => 2020-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 83284
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -131
[patent_words_short_claim] => 574
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17789023
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/789023 | TRANSCRIPTIONAL ENHANCED ASSOCIATE DOMAIN (TEAD) TRANSCRIPTION FACTOR INHIBITORS AND USES THEREOF | Dec 22, 2020 | Pending |
Array
(
[id] => 18160104
[patent_doc_number] => 20230026696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => TRPV4 RECEPTOR LIGANDS
[patent_app_type] => utility
[patent_app_number] => 17/778584
[patent_app_country] => US
[patent_app_date] => 2020-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28860
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17778584
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/778584 | TRPV4 RECEPTOR LIGANDS | Nov 19, 2020 | Pending |